Regulatory review time and post‐market safety events for novel medicines approved by the EMA between 2001 and 2010: a cross‐sectional study

By  

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 80, Iss. 4, 2015-10 ,pp. : 716-726

John Wiley & Sons Inc

Access to resources Recommend Favorite

Priority review drugs approved by the FDA and the EMA: time for international regulatory harmonization of pharmaceuticals?

By  

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, Vol. 24, Iss. 7, 2015-07 ,pp. : 709-715

John Wiley & Sons Inc

Access to resources Recommend Favorite

Post‐market safety warnings for drugs approved in Canada under the Notice of Compliance with conditions policy

By  

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 79, Iss. 5, 2015-05 ,pp. : 847-859

John Wiley & Sons Inc

Access to resources Recommend Favorite

A Cross-Sectional Study on the Relationship Between Utilization of Root Cause Analysis and Patient Safety at 139 Department of Veterans Affairs Medical Centers

By Percarpio Katherine B.   Watts Vince  

Joint Commission Journal on Quality and Patient Safety, Vol. 39, Iss. 1, 2013-01 ,pp. : 32-37

Joint Commission Resources

Access to resources Recommend Favorite

The cross‐sectional associations between objectively measured sedentary time and cardiometabolic health markers in adults – a systematic review with meta‐analysis component

By  

OBESITY REVIEWS, Vol. 19, Iss. 3, 2018-03 ,pp. : 381-395

John Wiley & Sons Inc

Access to resources Recommend Favorite